"Meldex’s first bidder is understood to be its founder and former chairman Barry Muncaster, who has built an 8.2 per cent stake. Landsbanki said that Meldex would be attractive to a US company with a minimal European distribution network and a complementary range of generic products, but it said that the price would probably be a small discount to its 95p target and recommended “hold”."
http://business.timesonline.co.uk/tol/business/markets/article3254641.ece